AL
REGN icon

Arnhold LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Arnhold LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.81M Hold
6,228
– – 0.35% 47
2025
Q4 		$4.81M Hold
6,228
– – 0.36% 46
2025
Q3 		$3.5M Hold
6,228
– – 0.29% 49
2025
Q2 		$3.27M Buy
+6,228
New +$3.48M 0.3% 50
2021
Q3 		– Sell
-1,051
Closed -$587K – 137
2021
Q2 		$587K Hold
1,051
– – 0.07% 96
2021
Q1 		$497K Hold
1,051
– – 0.06% 106
2020
Q4 		$508K Hold
1,051
– – 0.07% 114
2020
Q3 		$588K Hold
1,051
– – 0.09% 101
2020
Q2 		$655K Hold
1,051
– – 0.1% 91
2020
Q1 		$513K Buy
+1,051
New +$434K 0.09% 98

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Arnhold LLC's REGN Position: Q1 2026 in Review

Arnhold LLC held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 6,228 shares worth $4.81M. The position accounts for 0.35% of the portfolio, ranked #47.

Arnhold LLC first reported a position in REGN in Q1 2020 and has held it in 10 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Arnhold LLC held 6,228 shares of Regeneron Pharmaceuticals worth $4.81M as of Q1 2026.
  • Arnhold LLC left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.35% of Arnhold LLC's portfolio in Q1 2026, its #47 holding.
  • Arnhold LLC first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 10 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Arnhold LLC's 13F filing for Q1 2026, filed 11 May 2026.